ÆÈ´Ü±Ý µµÀÎ ¿îµ¿ÀÌ °íÇ÷¾Ð¿¡ ¹ÌÄ¡´Â ¿µÇâ : ü°èÀû ¹®Çå °íÂû
Baduanjin for Hypertension : Systematic Review
ôÃ߽ŰæÃß³ªÀÇÇÐȸÁö 2017³â 12±Ç 1È£ p.43 ~ p.56
Á¶ÇüÁØ(Cho Hyoung-Jun) - ºÎ»ê´ëÇб³ ÇÑÀÇÇÐÀü¹®´ëÇпø
¹èµ¿·Ä(Bae Dong-Ryeol) - ºÎ»ê´ëÇб³ ÇÑÀÇÇÐÀü¹®´ëÇпø
±èÈñ³ª(Kim Hee-Na) - ºÎ»ê´ëÇб³ ÇÑÀÇÇÐÀü¹®´ëÇпø
ȲÀÇÇü(Hwang Eui-Hyoung) - ºÎ»ê´ëÇб³ ÇÑÀÇÇÐÀü¹®´ëÇпø
Abstract
Objectives : To determine the effectiveness of Baduanjin for hypertension
Methods : We searched 8 electronic databases(Pubmed, CAJ, EMBASE, Cochrane Library, KISS, KISTI, NDSL, RISS) up to April 2017. We included randomized controlled trials(RCTs) using Badanjin for hypertension. The methodological quality of each RCT was assessed by the Cochrane risk of bias tool.
Results : 14 RCT studies were eligible in our review. 14 studies were divided into 4 groups, and 2 of them were meta-analysised. The meta-analysis of 10 studies showed favorable results for the use of Baduanjin with Usual care than Usual care. But, meta-analysis of 2 studies showed Baduanjin and Usual care has no difference. High risk of bias were observed in all studies.
Conclusions : Although there are favorable results with meta-analysis, our systematic review are highly dependent on the single source of Chinese electrical database, CAJ. Now limited evidence is available to support Baduanjin combined usual care for hypertension and further well-designed RCTs should be encouraged.
Å°¿öµå
Baduanjin, Hypertension, Systematic Review, Meta-Analysis, Traditional Korean Medicine
KMID :
1155620170120010043
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
Although there are favorable results with meta-analysis, this systematic review are highly dependent on the single source of Chinese electrical database